Recom COO Rodney Hildebrandt Signs Five-Year Agreement.

LOS ANGELES -- Recom Managed Systems, Inc. (OTBB: RECM), a life-sciences company developing patented heart-monitoring technology, today announced that the Board of Directors has secured a five-year employment commitment from Rodney Hildebrandt, Recom's Chief Operating Officer, Secretary and Board member. Terms of Mr. Hildebrandt's contract with Recom have been approved by the Board of Directors but have not been disclosed.

"Rod has already proven to be a critical part of the Recom team," said Pamela Bunes, president and chief executive officer of Recom. "His 30 years of experience in the healthcare industry, his expertise in corporate expansion and product distribution, and his demonstrated leadership abilities give me great confidence in the role he will play at Recom."

Mr. Hildebrandt, 56, was a founding executive of Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson. Most recently, he served as that company's director of corporate communications; prior to that, he was director of sales planning and operations. Mr. Hildebrandt previously served in various operational roles for other Johnson & Johnson companies, including multiple positions at the Dow Component Company, with responsibilities for manufacturing, distribution and materials management. Mr. Hildebrandt holds a Bachelor of Science degree in business management from the University of South Dakota.

About Recom Managed Systems, Inc.

Recom Managed Systems, Inc. is an emerging life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Recom Managed Systems, Inc. uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. With our patented signal-technology platform, Recom brings clinical-quality physiological signal monitoring to the ambulatory setting.

Recom Managed Systems, Inc. is traded on the OTC Bulletin Board under the symbol RECM.OB. More information is located at http://www.recom-systems.com.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknown risks, which may cause Recom's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of new products or services, failure to obtain federal or state regulatory approvals governing medical devices, monitoring and other related services or products, inability to obtain physician, patient or insurance acceptance of Recom's products or services, adverse equity-market conditions and declines in the value of Recom's common stock, and the unavailability of financing to complete management's plans and objectives. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Recom's filings with the Securities and Exchange Commission.